Our Company

MISSION AND VISION

BIOMAR Microbial Technologies is a biotech company founded in 1996, devoted to Marine Microbiology and Natural Products Chemistry.

Marine biodiversity is assumed to be higher than terrestrial, although marine studies have been under represented for decades due to the technical difficulties in bioprospecting the ocean.

Our goal is to discover, develop and produce new compounds and products of industrial interest.

The company strategic vision relies in two fundamental concepts: INNOVATION AND SUSTAINABILITY.

We offer a unique combination of both products and services based on marine microorganisms and the compounds they produce.

The diversity of our libraries, our team technical excellence and our large experience in the design and performance of research projects, have been the basis of our success in the development of products and processes in three major industrial sectors: Human Health and Cosmetics, Agriculture and Food Industry.

MILESTONES

1996

Biomar

Biomar arises as a spin off of PharmaMar (Grupo Zeltia)

1997

First bioprospections

Beginning of marine bioprospections that will constitute Biomar Libraries

1998

Human Health

humen Health focused on OFtalmology. Colaboration with ONCE.

1999

Human Health

Human Health new therapeutic areas antifectives and oncology

2000

Agriculture

Agrilculture biopesticides, new biotech area. R&D contract with Dupont.

2001

Production

Production kick off the Fermentation Pilot Plant

2002

New CEO

Dr. Antonio Fernández appointed new CEO

2003

Human Health

Human Health new therapeutic areas antiagiogenesis and neoroprotection.

2004

Microalgae

First Spanish insdustrial microalgae library.

2005

UE MIRACLE project

UEMIRACLE Project ISolation of uncultured marine microorganism.

2006

Share capital increase

First increase in company's share capital.

2007

Biodiesel

Identification of Microalgae for biodiesel production.

2008

Food Industry

Food Industry edible additives new biotech sector.

2009

New building

Brand new building in León Tech-Park

2010

+Production capacity

Quality Standards and increment of production capacity to 3000 L

2011

EPA approval

First Biomar's EPA approved product, herbicide Thaxtomin

2012

Cosmetics

Cosmetic Antiacne ingredient reaches the market in collaboration with Infinitec

2013

Financial Balance

The company fulfils financial balance and profit

2014

Valent BioSciences

Extension of Valent BioSciences Corporation contract. Bio-rational products.

2015

Human Health

Human Health reactivation. Adjustment of proceedings to Nagoya Protocol.

2016

4D Pharma PLC

Product Development and Production Area transfer to 4D Pharma PLC.

2017

Biopesticides

Recognition to the biopesticides strategic plan from Junta de Castilla y León

2018

PRESENT

MANAGEMENT TEAM

Dr. Antonio Fernández Medarde

CEO. Antonio got his PhD from the Univerisity of Texas, MD Anderson Cancer Center in Houston where he also did his postdoctoral studies in the Department of Cellular Biology and Molecular Pathology.

After that, he moved to Boston to work as a scientist under the supervision of Dr. Judah Folkman in the Department of Tumor Immunology at the Dana-Farber Cancer Institute and the Children's Hospital of Boston Surgical Research Laboratories, both associated to Harvard Medical School.

In 2001, he moved back to Spain joining the Research Unit at Hospital de León until February 2002 when he became part of Biomar’s team.

OUR CLIENTS

 

WordPress Theme built by Shufflehound. BIOMAR Microbial Technologies © 2017 - Ingeniado por nubedocs